Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · IEX Real-Time Price · USD
3.020
-0.040 (-1.31%)
At close: Apr 25, 2024, 4:00 PM
3.030
+0.010 (0.33%)
After-hours: Apr 25, 2024, 7:49 PM EDT
Cellectar Biosciences Market Cap
Cellectar Biosciences has a market cap or net worth of $97.43 million as of April 26, 2024. Its market cap has increased by 532.64% in one year.
Market Cap
97.43M
Enterprise Value
88.41M
1-Year Change
532.64%
Ranking
Category
Stock Price
$3.02
Market Cap Chart
Since November 10, 2005, Cellectar Biosciences's market cap has increased from $7.50M to $97.43M, an increase of 1,199.02%. That is a compound annual growth rate of 14.90%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2024 | 98.70M | -1.60% |
Apr 23, 2024 | 100.30M | -2.53% |
Apr 22, 2024 | 102.90M | 5.32% |
Apr 19, 2024 | 97.70M | -0.41% |
Apr 18, 2024 | 98.10M | -5.31% |
Apr 17, 2024 | 103.60M | -3.00% |
Apr 16, 2024 | 106.80M | -0.28% |
Apr 15, 2024 | 107.10M | -5.39% |
Apr 12, 2024 | 113.20M | -5.43% |
Apr 11, 2024 | 119.70M | 6.31% |
Apr 10, 2024 | 112.60M | -6.40% |
Apr 9, 2024 | 120.30M | -2.12% |
Apr 8, 2024 | 122.90M | 1.32% |
Apr 5, 2024 | 121.30M | 1.08% |
Apr 4, 2024 | 120.00M | -6.54% |
Apr 3, 2024 | 128.40M | -0.23% |
Apr 2, 2024 | 128.70M | 1.74% |
Apr 1, 2024 | 126.50M | -1.48% |
Mar 28, 2024 | 128.40M | 9.46% |
Mar 27, 2024 | 117.30M | 147.99% |
Mar 26, 2024 | 47.30M | -0.63% |
Mar 25, 2024 | 47.60M | -4.42% |
Mar 22, 2024 | 49.80M | 4.62% |
Mar 21, 2024 | 47.60M | 3.93% |
Mar 20, 2024 | 45.80M | -1.29% |
View and export this data all the way back to 2005.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eliem Therapeutics | 101.45M |
Anixa Biosciences | 101.44M |
Sangamo Therapeutics | 100.41M |
BioXcel Therapeutics | 100.36M |
Clearside Biomedical | 100.13M |
Myomo | 98.00M |
Envoy Medical | 97.61M |
FibroGen | 97.22M |